Request Deal Involvement

Gyrus Capital completed the acquisition of the heart valve business of LivaNova for $73m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Joele Frank

pr advisors

Joele Frank

Goldman Sachs

financial advisors

Goldman Sachs

Cleary Gottlieb Steen & Hamilton

legal advisors

Cleary Gottlieb Steen & Hamilton

Gatti Pavesi Bianchi Ludovici

legal advisors

Gatti Pavesi Bianchi Ludovici

Advant NCTM

legal advisors

Advant NCTM

Gowling WLG

legal advisors

Gowling WLG

Eversheds Sutherland

legal advisors

Eversheds Sutherland

Deloitte

financial advisors

Deloitte

Alira Health

commercial advisors

Alira Health

Medeor

financial advisors

Medeor

Medpass International

commercial advisors

Medpass International

DuPont Sustainable Solutions

environmental advisors

DuPont Sustainable Solutions

or

Principals

LIVANOVA PLC

vendor

LIVANOVA PLC

LIVANOVA PLC (HEART VALVE BUSINESS)

target

LIVANOVA PLC (HEART VALVE BUSINESS)

GYRUS CAPITAL

bidder

GYRUS CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Gyrus Capital completed the acquisition of the heart valve business of LivaNova for $73m.